Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 9/2004

01-09-2004 | Controversies-For

Primary hyperparathyroidism: is there a role for imaging?

Authors: Rudolf Roka, Michael Pramhas, Sebastian Roka

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 9/2004

Login to get access

Excerpt

“The best means of localisation is an experienced surgeon.” Although this sentiment can sometimes be found in publications, preoperative localisation of pathological parathyroid glands is a permanent endeavour. The reasons are obvious. With correct preoperative localisation, quick and guided identification of parathyroid adenomas can be achieved by the surgeon. This is especially important for reoperative surgery or in the presence of ectopic glands. Furthermore, operative time and surgical trauma are minimised, in accordance with the general trend within endocrine and other branches of surgery towards minimally invasive surgical techniques. …
Literature
1.
Fritsch A, Roka R, Niederle B. Operatives Vorgehen beim primären Hyperparathyreoidismus. In: Fritsch A, Geyer G, editors. Hyperparathyreoidismus. Diagnostik und Therapie der Nebenschilddrüsenüberfunktion. Wien: Urban und Schwarzenberg; 1982.
2.
Wang C. The anatomic basis of parathyroid surgery. Ann Surg 1976;183(3):271–5.PubMed
3.
Arici C, Cheah WK, Ituarte PH, et al. Can localization studies be used to direct focused parathyroid operations? Surgery 2001;129(6):720–9.CrossRefPubMed
4.
Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 2001;28(9):1351–9.CrossRefPubMed
5.
Hindie E, Melliere D, Jeanguillaume C, Urena P, deLabriolle Vaylet C, Perlemuter L. Unilateral surgery for primary hyperparathyroidism on the basis of technetium Tc 99m sestamibi and iodine 123 subtraction scanning. Arch Surg 2000;135(12):1461–8.CrossRefPubMed
6.
7.
Peeler BB, Martin WH, Sandler MP, Goldstein RE. Sestamibi parathyroid scanning and preoperative localization studies for patients with recurrent/persistent hyperparathyroidism or significant comorbid conditions: development of an optimal localization strategy. Am Surg 1997;63(1):37–46.PubMed
8.
Shen W, Duren M, Morita E, et al. Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg 1996;131(8):861–7.PubMed
9.
Gotway MB, Reddy GP, Webb WR, Morita ET, Clark OH, Higgins CB. Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism. Radiology 2001;218(3):783–90.PubMed
10.
Shen W, Sabanci U, Morita ET, Siperstein AE, Duh QY, Clark OH. Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy. Arch Surg 1997;132(9):969–74.PubMed
11.
Wakamatsu H, Noguchi S, Yamashita H, et al. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with 99mTc-MIBI, 201Tl, MRI and US. Eur J Nucl Med 2001;28(12):1817–27.CrossRefPubMed
12.
Walgenbach S, Dulkowski P, Andreas J, Görges R, Bockisch A, Junginger T. 99mTc-MIBI-Szintigraphie vor Eingriffen wegen Hyperparathyreoidismus? Zentralbl Chir 1999;124:214–9.PubMed
13.
Joseph K, Welcke U, Hoffken H, Koppelberg T, Rothmund M. Szintigraphische Darstellung von Adenomen der Nebenschilddruse mit 99mTc-Sestamibi in einem Strumaendemiegebiet. Nuklearmedizin 1994;33(3):93–8.PubMed
14.
Weiss M, Beneke F, Schmid R, Dresel S, Hahn K. Kann durch den zusatzlichen Einsatz der SPECT-Technik die diagnostische Aussage der praoperativen Tc-99m-MIBI-Szintigraphie beim primaren Hyperparathyreoidismus verbessert werden? Med Klin (Munich) 2002;97(7):389–95.CrossRef
15.
Profanter C, Wetscher GJ, Gabriel M, et al. CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism. Surgery 2004;135(2):157–62.CrossRefPubMed
16.
Mundschenk J, Klose S, Lorenz K, Dralle H, Lehnert H. Diagnostic strategies and surgical procedures in persistent or recurrent primary hyperparathyroidism. Exp Clin Endocrinol Diabetes 1999;107(6):331–6.PubMed
17.
Thompson GB, Grant CS, Perrier ND, et al. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg 1999;134(7):699–704.CrossRefPubMed
18.
Boggs JE, Irvin GL III, Molinari AS, Deriso GT. Intraoperative parathyroid hormone monitoring as an adjunct to parathyroidectomy. Surgery 1996;120(6):954–8.PubMed
19.
Reeve TS, Babidge WJ, Parkyn RF, et al. Minimally invasive surgery for primary hyperparathyroidism: systematic review. Arch Surg 2000;135(4):481–7.CrossRefPubMed
20.
Greene AK, Mowschenson P, Hodin RA. Is sestamibi-guided parathyroidectomy really cost-effective? Surgery 1999;126(6):1036–40.CrossRefPubMed
21.
Passler C, Avanessian R, Kaczirek K, et al. Schilddrüsenchirurgie im Alter. Eur Surg—Acta Chirurgica Austriaca 2001;33(6):288–93.CrossRef
Metadata
Title
Primary hyperparathyroidism: is there a role for imaging?
Authors
Rudolf Roka
Michael Pramhas
Sebastian Roka
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 9/2004
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-004-1619-5

Other articles of this Issue 9/2004

European Journal of Nuclear Medicine and Molecular Imaging 9/2004 Go to the issue

Original Article

Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3

Original Article

The performance of 18F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules

Original Article

Positron emission tomography imaging of adrenal masses: 18F-fluorodeoxyglucose and the 11β-hydroxylase tracer 11C-metomidate

Letter to the Editor

Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy

Letter to the Editor

Reply

Original Article

A comparison of 111In-DOTATOC and 111In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours